DE279489C - - Google Patents

Info

Publication number
DE279489C
DE279489C DENDAT279489D DE279489DA DE279489C DE 279489 C DE279489 C DE 279489C DE NDAT279489 D DENDAT279489 D DE NDAT279489D DE 279489D A DE279489D A DE 279489DA DE 279489 C DE279489 C DE 279489C
Authority
DE
Germany
Prior art keywords
inkwell
ink
plug
inkwells
immersion opening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT279489D
Other languages
German (de)
English (en)
Publication of DE279489C publication Critical patent/DE279489C/de
Active legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B43—WRITING OR DRAWING IMPLEMENTS; BUREAU ACCESSORIES
    • B43L—ARTICLES FOR WRITING OR DRAWING UPON; WRITING OR DRAWING AIDS; ACCESSORIES FOR WRITING OR DRAWING
    • B43L25/00—Ink receptacles

Landscapes

  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Pens And Brushes (AREA)
DENDAT279489D Active DE279489C (OSRAM)

Publications (1)

Publication Number Publication Date
DE279489C true DE279489C (OSRAM)

Family

ID=535399

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT279489D Active DE279489C (OSRAM)

Country Status (1)

Country Link
DE (1) DE279489C (OSRAM)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10731139B2 (en) 2005-04-11 2020-08-04 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US10823727B2 (en) 2009-06-25 2020-11-03 Horizon Pharma Rheumatology Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12465631B2 (en) 2019-01-30 2025-11-11 Horizon Therapeutics Usa, Inc. Reducing immunogenicity to pegloticase
US12496331B2 (en) 2016-11-11 2025-12-16 Horizon Therapeutics Usa, Inc. Combination therapies of prednisone and uricase molecules and uses thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10731139B2 (en) 2005-04-11 2020-08-04 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US11345899B2 (en) 2005-04-11 2022-05-31 Horizon Therapeutics Usa, Inc. Variant forms of urate oxidase and use thereof
US11781119B2 (en) 2005-04-11 2023-10-10 Horizon Therapeutics Usa, Inc. Variant forms of urate oxidase and use thereof
US10823727B2 (en) 2009-06-25 2020-11-03 Horizon Pharma Rheumatology Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US11598767B2 (en) 2009-06-25 2023-03-07 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US11639927B2 (en) 2009-06-25 2023-05-02 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US11982670B2 (en) 2009-06-25 2024-05-14 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12188927B2 (en) 2009-06-25 2025-01-07 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US12560596B2 (en) 2009-06-25 2026-02-24 Amgen Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12496331B2 (en) 2016-11-11 2025-12-16 Horizon Therapeutics Usa, Inc. Combination therapies of prednisone and uricase molecules and uses thereof
US12465631B2 (en) 2019-01-30 2025-11-11 Horizon Therapeutics Usa, Inc. Reducing immunogenicity to pegloticase

Similar Documents

Publication Publication Date Title
DE2935698A1 (de) Vorrichtung zum abtoenen von anstrichsfarben
DE2711591A1 (de) Behaelter fuer die abgabe von fluessigkeiten
DE2555321C3 (de) Behälter zum Aufbewahren, Ausstellen und Servieren von insbesondere blockförmigen Speisen
DE3600652C1 (de) Flaschenverschluss,insbesondere fuer Schaumweinflaschen
DE3516890A1 (de) Behaelterverschluss mit einem aufhaenger
DE4439869A1 (de) Mehrteilige Flasche
DE623884C (de) Bruehvorrichtung aus keramischem Werkstoff
DE2238150A1 (de) Gewuerzstreuer
DE3619490A1 (de) Elektrisches geraet zum zubereiten heisser getraenke, wie kaffee, tee oder dgl.
DE8013379U1 (de) Behaelter zur Aufnahme von schuettfaehigem oder fliessfaehigem Gut
CH605308A5 (en) Bottle seal with pouring device
DE508867C (de) Bronze- und Tinkturbehaelter
DE386652C (de) Zusammenlegbarer Kleiderhaken
DE709080C (de) Ausgussstopfen fuer Flaschen
DE1969055U (de) Behaelter fuer draehte.
DE20103948U1 (de) Behälter zur Aufnahme von runden Kuchen, z.B. Torten
DE2724337A1 (de) Verschlusskappe
DE1140857B (de) Ausgabeverschluss bei Schuettgutbehaeltern
DE19513650A1 (de) Behälter
DE1482581A1 (de) Ausgiesser fuer Flaschen
DE2039096C (de) Wiederverwendbarer Formbehalter für Lebensmittel, die als formbare Masse in den Behalter gegeben und zu einer die Gestalt des Behalters behaltenden festen Masse geformt werden
DE1878367U (de) Stapelfaehiger fluessigkeitsbehaelter mit ausguss.
DE1020562B (de) Vorrichtung zur dosenweisen Entnahme von gemahlenem, koernigem oder fluessigem Fuellgt aus Behaeltern
DE29912051U1 (de) Farbschale für wasserlösliche Malfarben und Behälter zur Aufnahme derartiger Farbschalen
DE1928960U (de) Behaelter fuer eine dosierte pulvermenge zur bereitung von tafelwasser.